Product Name:

LCL-161

Request LCL-161
CAT#: A-1147

Chemical Structure

LCL-161 structure
(S)-N-((S)-1-Cyclohexyl-2-{(S)-2-[4-(4-fluorobenzoyl)thiazol-2- yl]pyrrolidin-1-yl}-2-oxoethyl)-2-methylamino-propionamide

Price of LCL-161


We offer a substantial discount on larger orders,
please inquire via sales@activebiochem.com
or Fax: 1-201-884-1288(USA Fax#)

We match the lowest price on market.

Biological Activity

LCL161 is an orally bioavailable second mitochondrial-derived activator of caspases (SMAC) mimetic and inhibitor of IAP (Inhibitor of Apoptosis Protein) family of proteins, with potential antineoplastic activity. SMAC mimetic LCL161 binds to IAPs, such as X chromosome-linked IAP (XIAP) and cellular IAPs 1 and 2. Since IAPs shield cancer cells from the apoptosis process, this agent may restore and promote the induction of apoptosis through apoptotic signaling pathways in cancer cells. IAPs are overexpressed by many cancer cell types and suppress apoptosis by binding and inhibiting active caspases-3, -7 and -9, which play essential roles in apoptosis (programmed cell death), necrosis and inflammation.
Technical Data

Molecular Formula: C26H33FN4O3S
Molecular Weight: 500.23
CAS#: 1005342-46-0
Purity: >99%
Storage Conditions: 2ºC to 8 ºC, or -20ºC for 2 years.
LCL-161 MSDS LCL-161 CoA
Reference